Production of a malaria transmission-blocking protein from recombinant yeast.
Wang
M Y
MY
Biotechnology Unit NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.
Kaslow
D C
DC
Shiloach
J
J
D000818:Animals; D003001:Cloning, Molecular / Q000379:methods*; D009033:Culicidae; D000431:Ethanol / Q000378:metabolism; D005285:Fermentation; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008288:Malaria / Q000276:immunology*; D017780:Malaria Vaccines / Q000096:biosynthesis*; D015800:Protozoan Proteins / Q000096:biosynthesis* / Q000302:isolation & purification; D016052:Protozoan Vaccines; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000302:isolation & purification; D012441:Saccharomyces cerevisiae / Q000254:growth & development; D016324:Sequence Tagged Sites; D014614:Vaccines, Synthetic / Q000096:biosynthesis
D017780:Malaria Vaccines; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; C099774:transmission-Blocking Vaccine based on Pfs25; D000431:Ethanol